Back to Trades
Total Value
$412.9K
Net $180.9K sold
Filing Date
Sep 23, 2025
1 transaction
Sales
$180.9K
1 transaction
Trade Summary
On Sep 19, 2025 through Sep 22, 2025, AULT MILTON C III, Insider, sold $412.9K of Alzamend Neuro, Inc. (ALZN) across 1 transaction. The filing covers Common Stock and reflects net selling of $180.9K. Reported prices ranged from $2.32 to $2.35. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Alzamend Neuro, Inc.
- Ticker Symbol
- ALZN
- CIK
- 0001677077
Insider Information
- Role
- Insider
- Location
- LAS VEGAS, NV
Filing Details
- Filing Date
- Sep 23, 2025
- Transaction Date
- Sep 19, 2025
- Accession Number
- 0001214659-25-014056
- Form Type
- 4
- Net Trading Amount
- -$180.9K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Sep 19, 2025 | Common Stock | 77,009 | $2.35 | Sale | $180.9K |
| Sep 22, 2025 | Common Stock | 100,000 | $2.32 | C | $232.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Sep 22, 2025 | ALZN derivative | 232 | — | C | — |
Want live alerts when AULT MILTON C III trades again?
Download Insider Trades to track ALZN, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
- (F2)Represents shares of common stock received upon conversion of Series B convertible preferred stock ("Series B Preferred").
- (F3)Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
- (F4)Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
- (F5)The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock.
- (F6)The shares of Series B Preferred have no expiration date.